Chorionic Villus Sampling (CVS): Procedure, Risks and Benefits

What Is Chorionic Villus Sampling (CVS)? Introduction and Uses

Chorionic Villus Sampling (CVS) is a prenatal diagnostic procedure used to examine the genetic health of a developing baby during the early stages of pregnancy. In this test, a small sample of placental tissue—called chorionic villi—is collected and analysed in a laboratory. Because these cells share the same genetic material as the fetus, doctors can study them to identify potential chromosomal or inherited conditions.

CVS is typically performed between the 10th and 13th week of pregnancy, which makes it one of the earliest forms of Prenatal Genetic Testing available. By obtaining genetic information at an early stage, healthcare professionals can provide parents with important insights about the baby’s development and possible genetic disorders.

The primary purpose of Chorionic Villus Sampling is to support accurate Genetic Testing for conditions such as Down syndrome, Tay‑Sachs disease, cystic fibrosis, and other inherited disorders. Because the results are available relatively early in pregnancy, CVS allows parents and medical teams more time to discuss medical care, further testing, or pregnancy management options if necessary.

In modern prenatal medicine, Chorionic Villus Sampling plays a significant role in early diagnosis and informed decision‑making. When recommended by healthcare providers—often for pregnancies with increased genetic risk—it can provide valuable information about fetal genetics while pregnancy is still in its early stages.

Procedure and Methods of Chorionic Villus Sampling

Chorionic Villus Sampling (CVS) is a medical procedure used to collect a small sample of placental tissue for genetic analysis. The test is usually performed under ultrasound guidance to ensure accuracy and safety. During the procedure, a specialist carefully removes a tiny sample of chorionic villi from the placenta so the cells can be examined in a laboratory for chromosomal or inherited conditions.

There are two main techniques used to perform Chorionic Villus Sampling, and the choice of method depends on factors such as the position of the placenta, the stage of pregnancy, and the physician’s clinical judgement.

Transabdominal Chorionic Villus Sampling

In the transabdominal approach, the sample is taken through the mother’s abdomen.

• The doctor first uses ultrasound to locate the placenta and the fetus.
• The skin on the abdomen is cleaned and sometimes numbed with a local anaesthetic.
• A thin needle is gently inserted through the abdominal wall and into the placenta.
• A small sample of chorionic villi is withdrawn for laboratory testing.

This method is commonly used and is similar in technique to amniocentesis. Ultrasound guidance helps ensure the needle avoids the fetus and other sensitive structures.

Transcervical Chorionic Villus Sampling

The transcervical approach involves collecting the placental sample through the cervix.

• An ultrasound is performed to determine the exact location of the placenta.
• A thin catheter or specialised instrument is inserted through the vagina and cervix.
• The device gently reaches the placenta and removes a small tissue sample.
• The sample is then sent to a laboratory for detailed genetic analysis.

This method may be recommended when the placenta is positioned in a way that makes cervical access easier and safer.

Both techniques of Chorionic Villus Sampling (CVS) are typically completed within a short time and are performed by experienced specialists in a clinical setting. After the procedure, patients are usually advised to rest for a short period while doctors monitor for any immediate discomfort or complications.

What Conditions Can Be Detected Through Chorionic Villus Sampling?

Chorionic Villus Sampling (CVS) is an advanced prenatal diagnostic test that can detect a wide range of chromosomal and genetic disorders early in pregnancy. Because chorionic villi contain the same genetic material as the fetus, laboratory analysis of these cells allows specialists to identify abnormalities with high accuracy.

Key categories of genetic and chromosomal conditions detected by CVS.

Chromosomal Abnormalities

Conditions caused by extra, missing, or altered chromosomes.

CVS is commonly used to diagnose chromosomal disorders that occur when the number or structure of chromosomes changes. Examples include Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), Turner syndrome (Monosomy X), and Klinefelter syndrome (XXY).

Trisomy Conditions

Extra copies of specific chromosomes.

Trisomy disorders occur when a fetus has three copies of a chromosome instead of two. Common examples include Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), which can affect physical development, learning ability, and overall health.

Single‑Gene Disorders

Inherited diseases caused by mutations in a single gene.

CVS can identify many genetic conditions that result from mutations in a single gene. Examples include cystic fibrosis, Tay‑Sachs disease, sickle cell disease, thalassemia, muscular dystrophies, and Fragile X syndrome. Testing is particularly valuable when one or both parents are known carriers.

Metabolic and Biochemical Disorders

Conditions affecting how the body processes nutrients.

In certain cases, specialised laboratory testing on CVS samples can detect metabolic disorders. These conditions may interfere with how the body processes proteins, fats, or carbohydrates and can impact growth, energy production, and overall metabolism.

Complex Genetic Syndromes

Syndromes involving multiple body systems.

CVS can also help detect certain genetic syndromes that affect multiple organs or body systems. The specific conditions identified depend on the type of genetic testing requested and the medical history of the pregnancy.

Key Takeaway:

Chorionic Villus Sampling provides early and highly accurate detection of chromosomal abnormalities, inherited single‑gene disorders, and certain metabolic or genetic syndromes, helping guide prenatal care and informed decision‑making.

Who Should Consider Chorionic Villus Sampling?

Chorionic Villus Sampling (CVS) is not routinely recommended for every pregnancy. Instead, it is usually offered to individuals or couples who may have a higher risk of passing on genetic or chromosomal conditions to their baby. Because the procedure is a diagnostic test, healthcare providers typically suggest it when there is a medical reason to obtain more detailed genetic information during early pregnancy.

Several factors may make someone a suitable candidate for Chorionic Villus Sampling.

Advanced Maternal Age

One of the most common reasons for recommending Chorionic Villus Sampling (CVS) is advanced maternal age. Pregnant individuals aged 35 or older have a higher statistical risk of chromosomal abnormalities such as Down syndrome, which may lead doctors to suggest diagnostic testing.

Family History of Genetic Disorders

If there is a family history of inherited conditions, doctors may recommend Chorionic Villus Sampling to determine whether the fetus has inherited the same genetic disorder. This is especially relevant for conditions such as cystic fibrosis, sickle cell disease, or Tay‑Sachs disease.

Parents Who Are Known Genetic Carriers

When one or both parents are known carriers of a specific genetic mutation, Chorionic Villus Sampling can be used to determine whether the baby has inherited the condition. Carrier screening performed before or during pregnancy often helps identify these risks.

Abnormal Prenatal Screening Results

Sometimes routine prenatal screening tests or ultrasound findings suggest a higher probability of chromosomal abnormalities. In such situations, doctors may recommend Chorionic Villus Sampling (CVS) to confirm or rule out a diagnosis.

Previous Pregnancy with a Genetic Condition

Couples who previously had a pregnancy affected by a chromosomal or inherited disorder may also be advised to consider Chorionic Villus Sampling in future pregnancies to assess potential risks early.

In most cases, doctors recommend genetic counselling before performing Chorionic Villus Sampling. This helps parents understand the benefits, possible risks, and limitations of the test so they can make an informed decision about whether the procedure is appropriate for their pregnancy.

Risks and Possible Complications of Chorionic Villus Sampling (CVS)

While Chorionic Villus Sampling (CVS) is considered a reliable and widely used diagnostic procedure, it is still an invasive test and therefore carries certain risks. Understanding these risks helps parents make informed decisions and prepares them for possible post‑procedure precautions. The likelihood of complications is generally low when the procedure is performed by experienced specialists, but it is important to be aware of the potential issues.

Risk of Miscarriage

One of the most discussed risks of Chorionic Villus Sampling is miscarriage.

• The estimated risk is slightly higher than that of routine pregnancy loss, often cited as about 0.2% to 0.3% depending on the medical centre and technique used.
• The risk is influenced by factors such as maternal health, placental position, and whether the procedure is performed via the transabdominal or transcervical method.

Most miscarriages, if they occur, happen within a few days of the procedure.

Risk of Infection

Although rare, an infection can occur either inside the uterus or at the site of needle entry (for the transabdominal method).

• Fever, abdominal pain, unusual discharge, or chills after CVS should be reported to a healthcare provider immediately.

Strict sterile techniques significantly reduce this risk.

Leakage of Amniotic Fluid

In uncommon cases, leakage of amniotic fluid may occur after CVS, particularly with the transcervical approach.

• Mild, temporary leakage often resolves on its own.
• Persistent leakage requires medical evaluation, as it may increase the risk of complications later in pregnancy.

Bleeding or Spotting

Light spotting or mild bleeding can occur after the transcervical method.

• This usually resolves without intervention.
• However, heavy or prolonged bleeding should always be assessed by a doctor.

Rh Sensitisation

In pregnancies where the mother is Rh‑negative, CVS may expose fetal blood cells to the mother’s bloodstream.

• To prevent sensitisation, an anti‑D injection (RhoGAM) is typically given after the procedure.

This avoids complications in current and future pregnancies.

Discomfort or Cramping

Mild abdominal cramping or discomfort is common following the procedure.

• Resting for the remainder of the day is usually recommended.
• Severe or persistent pain should be reported to a healthcare provider.

Overall, while Chorionic Villus Sampling (CVS) carries some risks, they remain relatively low when the procedure is performed by trained specialists. Clear communication with healthcare providers, proper post‑procedure monitoring, and timely reporting of unusual symptoms help ensure the safest possible experience for both mother and baby.